
Michel Bouvier, PhD
Chief Executive Officer of the Institute for Research in Immunology and Cancer at the University of Montréal
Michel Bouvier, PhD, is Chief Executive Officer of the Institute for Research in Immunology and Cancer (IRIC) at the University of Montréal. His research focuses on deciphering the molecular mechanisms that regulate GPCRs. Many of his groundbreaking findings have over the years led to significant paradigm shifts in the field and paved the way for alternative strategies to develop novel and safer drugs targeting GPCRs. His contributions to the field of Molecular Pharmacology were recognized by the attribution of many awards.
Ermium Therapeutics © 2023 All Rights Reserved
Design by Cédric Adam